Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
+7.2M
-
Total reported value, excl. options
-
$277M
-
Value change
-
+$136M
-
Number of buys
-
48
-
Number of sells
-
-12
-
Price
-
$19.48
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q3 2018
64 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q3 2018.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 1.09B outstanding shares and own 1.32% of the company stock.
Largest 10 shareholders include Segantii Capital Management Ltd (2.4M shares), BAMCO INC /NY/ (1.9M shares), ORBIMED ADVISORS LLC (1.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (945K shares), Myriad Asset Management Ltd. (891K shares), GILDER GAGNON HOWE & CO LLC (838K shares), Cormorant Asset Management, LP (808K shares), Vanguard Group Inc (768K shares), EcoR1 Capital, LLC (350K shares), and Rock Springs Capital Management LP (350K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.